Oxaliplatin

奥沙利铂

Report date: 2023/05/05 17:40:50
NME

Base Information

Drug NameOxaliplatin
Drug Alias Name草酸铂Oxaliplatino奥克赛铂OxaliplatineDACH-platin polymeric micelle +[26
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agents
TargetsDNA
Therapy Area/IndicationsCNS Embryonal TumorLiver DysfunctionSolid tumours +[59
Global Approved IndicationsPancreatic NeoplasmsStomach NeoplasmsColonic Neoplasms +[5
Approved Indications in ChinaColorectal Neoplasms
Original Approved Country/TerritoryFrance
Original Approved Date1996/01/01
Country/TerritoryBelgiumCanadaUnited States +[27
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[7
Inactive IndicationsCNS Embryonal TumorLiver DysfunctionSolid tumours +[52

Other Information

ATC CodeL01XA03